The ADAPT Program to support the management of anxiety and depression in adult cancer patients: a cluster randomised trial to evaluate different implementation strategies.

Not Applicable

Completed

• Conditions: Cancer; Mental Health; Cancer - Any cancer; Mental Health - Anxiety; Mental Health - Depression

• Registration Number: ACTRN12617000411347
• Lead Sponsor: Psycho-oncology Co-operative Research Group (PoCoG)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-03-22
• Study Completion: 2021-06-08
• Last Update Posted: 21 February 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1280

Inclusion Criteria

This study has 3 groups of research participants:
1. Group 1 is the site
2. Group 2 is the staff at the participating sites
3. Group 3 is the patients at the participating sites.

Group 1: Cancer services (sites)
Cancer services in New South Wales are eligible to participate providing they commit to the following:
1. Formally agree to participate at the site level
2. Sign an ADAPT Research Participation Agreement
3. Endorse and enable staff training
4. Allow a complete site profile audit
5. Allow release of their Organisational Chart
6. Authorise release of MBS/PBS provider information and statistics

Sites will be required to have the following IT infrastructure:
1. Wi-Fi/broadband/internet access
2. Internet browser version to comply with Portal requirements

Sites will be required to have the following characteristics:
1.. At least 50% of patient population have cancer
2. At least 100 active patients
3. At least 1 IT liaison contact person
4. At least 1 local champion

Group 2: Cancer service staff
1. Employed on an ongoing (6 months or more) or permanent basis, either full or part time or as a visiting medical officer at a participating centre
2. Work in a role that provides clinical care to patients with cancer or client focused administrative support or IT/managerial support.
3. Aged 18 years and over
4. Staff will be identified as part of the organisation chart mapping exercise at site engagement.
5. Participation in giving feedback is voluntary

Group 3: Patients
1. Recruitment for this study will be at the site level so any patients seen at participating sites will be exposed to the outcome of the intervention as part of their usual care.
2. Adult patients (aged 18 and over) who have cancer of any type will be offered screening as part of their routine care by cancer service staff.
3. Patients choose whether to take part in screening or not.

Exclusion Criteria

Group 1: Sites
Cancer services who are unable to commit to the mandatory study components will be excluded.
Group 2: Staff
Casual staff, and any staff member under the age of 18 are unable to take part.. Staff who have no clinical or administrative contact with cancer patients, and IT staff who are not involved in the implementation of the ADAPT RCT are also excluded.
Group 3: Patients
Patients who do not consent to sharing their MBS and PBS data will not be included in secondary outcome analyses.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adherence to the Clinical Pathway for the Screening, Assessment and Management of Anxiety and Depression in Adult Cancer Patients. <br><br>The primary outcome of adherence will be measured using a study-developed measure, capturing information about screening, information provision, emotional support, triage, referral, uptake and progress review, as specified in the Clinical Pathway. Adherence will be calculated as a percentage of patients at each site whose care is considered adherent to the Clinical Pathway. Adherence information required for the measure will be collected from the patient medical records.<br>[Endpoint: 12 months after intervention commences. ]